CD8A and COVID-19: Due to its predictive power for adverse clinical outcomes in HIV infection and in the ageing general population75–77, including its potential role as a prognostic factor of COVID-19 disease severity24, the CD4:CD8 ratio could represent an additional tool for risk stratification of PLWH.